文献速递心律失常瓣膜病与结构性心脏病

成人先天性心脏病中的室性心律失常(第二部分):JACC 前沿综述

Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

本综述将高风险先天性心脏病患者按室性心动过速基质分为两类:具有离散解剖峡部的宏折返性室速(A组)和基质弥漫或界限不清者(B组)。B组包括Ebstein畸形、大动脉转位伴体循环右室及先天性主动脉瓣狭窄,其多形性室速和室颤比例更高,程序电刺激的预后价值及导管消融的作用相对有限。

要点

  • 先天性心脏病患者室速基质分为离散解剖峡部(A组)和弥漫/界限不清(B组)两类。
  • B组包括Ebstein畸形、大动脉转位伴体循环右室和先天性主动脉瓣狭窄。
  • B组中多形性室速和室颤占室性心律失常比例更高,导管消融作用有限。

核心结论

  • 先天性心脏病患者室性心律失常的基质和猝死风险因缺损类型而异,B组患者多形性室速和室颤比例更高。

研究设计与样本

  • 本文为JACC前沿综述,将高风险先天性心脏病患者概念性分为A组(离散解剖峡部)和B组(弥漫或界限不清基质)。

主要发现

  • B组包括Ebstein畸形、大动脉转位伴体循环右室和先天性主动脉瓣狭窄等病变。
  • B组中多形性室速和室颤占室性心律失常比例更高。
  • B组程序电刺激的预后价值尚不明确,导管消融作用有限。
  • 随着心肌病进展,A组和B组的室性心律失常病理生理机制逐渐模糊。

临床怎么用

  • 对B组先天性心脏病患者应警惕多形性室速和室颤,导管消融决策需谨慎评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There are marked variations in the incidence of sudden cardiac death (SCD) and in the substrates for ventricular arrhythmias (VAs) across the gamut of congenital heart defects. In this 2-part review, patients with higher-risk forms of congenital heart disease (CHD) were conceptually categorized into those with discrete anatomic isthmuses for macro-reentrant ventricular tachycardia (VT) (Group A) and those with more diffuse or less well-defined substrates (Group B) that include patchy or extensive myocardial fibrosis. The latter category encompasses CHD lesions such as Ebstein anomaly, transposition of the great arteries with a systemic right ventricle (RV), and congenital aortic stenosis. For Group B patients, polymorphic VT and ventricular fibrillation account for a higher proportion of VA. The prognostic value of programmed ventricular stimulation is less well established, and catheter ablation plays a less prominent role. As cardiomyopathies evolve over time, pathophysiological mechanisms for VA among Groups A and B become increasingly blurred.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Bessière F, Waldmann V, Combes N, et al. Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023. PMID: 37673513. doi:10.1016/j.jacc.2023.06.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。